Tower Research Capital (TRC)’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-49,918
Closed -$123K 6072
2020
Q4
$123K Sell
49,918
-143,836
-74% -$350K ﹤0.01% 2156
2020
Q3
$610K Buy
193,754
+133,229
+220% +$426K 0.01% 1470
2020
Q2
$176K Buy
60,525
+57,180
+1,709% +$181K 0.01% 1901
2020
Q1
$9K Buy
3,345
+664
+25% +$2.14K ﹤0.01% 2102
2019
Q4
$8K Sell
2,681
-6,147
-70% -$17.8K ﹤0.01% 2489
2019
Q3
$19K Buy
8,828
+8,528
+2,843% +$22.8K ﹤0.01% 2527
2019
Q2
$1K Sell
300
-32
-10% -$104 ﹤0.01% 3576
2019
Q1
$1K Buy
+332
New +$1.12K ﹤0.01% 3711
2018
Q4
Sell
-4,890
Closed -$13K 4800
2018
Q3
$13K Sell
4,890
-3,680
-43% -$9.03K ﹤0.01% 2633
2018
Q2
$20K Buy
8,570
+1,295
+18% +$3.62K ﹤0.01% 2454
2018
Q1
$21K Buy
7,275
+2,548
+54% +$6.96K ﹤0.01% 2164
2017
Q4
$13K Sell
4,727
-960
-17% -$2.95K ﹤0.01% 2419
2017
Q3
$19K Buy
5,687
+2,684
+89% +$7.46K ﹤0.01% 2773
2017
Q2
$7K Buy
+3,003
New +$6.91K ﹤0.01% 1861
2016
Q3
Sell
-958
Closed -$3K 5253
2016
Q2
$3K Sell
958
-3,342
-78% -$11.1K ﹤0.01% 3831
2016
Q1
$14K Sell
4,300
-7
-0.2% -$22 ﹤0.01% 1675
2015
Q4
$15K Buy
+4,307
New +$18K ﹤0.01% 1662
2015
Q2
Sell
-99
Closed -$1K 5686
2015
Q1
$1K Sell
99
-2,964
-97% -$21.5K ﹤0.01% 4319
2014
Q4
$23K Buy
3,063
+3,058
+61,160% +$24.2K ﹤0.01% 1521
2014
Q3
$0 Sell
5
-95
-95% -$882 ﹤0.01% 5449
2014
Q2
$1K Sell
100
-5,986
-98% -$53.4K ﹤0.01% 3917
2014
Q1
$51K Buy
6,086
+5,888
+2,974% +$50.5K 0.01% 1089
2013
Q4
$2K Sell
198
-13,252
-99% -$112K ﹤0.01% 4155
2013
Q3
$107K Buy
+13,450
New +$108K 0.01% 1235

Other funds holding PDLI